Publications found:
43,318
Sort by:
2013 US Hospital Cancer Diagnostics Market
US$ 5,200.00
This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...
December 2012
567 pages
2013 France Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
542 pages
2013 Germany Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
578 pages
2013 Italy Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
561 pages
2013 Japan Clinical Chemistry and Immunodiagnostics Markets
US$ 5,440.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
559 pages
2013 Spain Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
568 pages
2013 UK Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
563 pages
2013 US Clinical Chemistry and Immunodiagnostics Markets
US$ 8,560.00
... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...
December 2012
600 pages
2013 France Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 2,880.00
... -page report from Venture Planning Group presents a comprehensive analysis of the French flow cytometry market, including: Major issues pertaining to the French ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
146 pages
2013 Germany Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 2,880.00
... -page report from Venture Planning Group presents a comprehensive analysis of the German flow cytometry market, including: Major issues pertaining to the German ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
147 pages
2013 Italy Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 2,880.00
... -page report from Venture Planning Group presents a comprehensive analysis of the Italian flow cytometry market, including: Major issues pertaining to the Italian ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
142 pages
2013 Japan Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 3,600.00
... page report from Venture Planning Group presents a comprehensive analysis of the Japanese flow cytometry market, including: Major issues pertaining to the Japanese ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
142 pages
2013 Spain Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 2,880.00
... -page report from Venture Planning Group presents a comprehensive analysis of the Spanish flow cytometry market, including: Major issues pertaining to the Spanish ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
140 pages
2013 UK Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 2,880.00
... new 146-page report from Venture Planning Group presents a comprehensive analysis of the UK flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
146 pages
2013 US Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 4,720.00
... new 174-page report from Venture Planning Group presents a comprehensive analysis of the US flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
174 pages
2013 France Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 585-page analysis of the French tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
585 pages
2013 Italy Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 570-page analysis of the Italian tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
570 pages
2013 Germany Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 585-page analysis of the German tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
585 pages
2013 Japan Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 5,360.00
Highlights This new 590-page analysis of the Japanese tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
590 pages
2013 Spain Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 565-page analysis of the Spanish tumor marker testing market report from Venture Planning Group including: Major ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
595 pages
2013 UK Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 4,320.00
Highlights This new 575-page analysis of the UK tumor marker testing market report from Venture Planning Group including: Major issues ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
575 pages
2013 US Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 6,960.00
Highlights This new 620-page analysis of the US tumor marker testing market report from Venture Planning Group including: Major issues ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
620 pages
2013 CEA Testing Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
US$ 3,080.00
... report from Venture Planning Group presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ... disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...
December 2012
250 pages
2013 Occult Blood Testing Market: US, Europe, Japan Test Volume and Sales Forecasts by Country
US$ 3,080.00
... from Venture Planning Group presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...
December 2012
243 pages
2013 Pap Smear/HPV Testing Market: US, Europe, Japan Test Volume and Sales Forecasts by Country
US$ 3,080.00
... from Venture Planning Group presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...
December 2012
243 pages
2013 PSA Testing Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
US$ 3,080.00
... report from Venture Planning Group presents a detailed analysis of the PSA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, ... disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated ...
December 2012
249 pages
2013 Factor Assays: US, Europe, Japan Test Volume Forecasts by Country and Market Segment
US$ 3,800.00
This new 295-page report from Venture Planning Group presents a detailed analysis of the Factor Assays testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and ...
December 2012
295 pages
